Join the Prevnar 13 group to help and get support from people like you.
Prevnar 13 News
Pfizer Receives FDA Approval for Prevnar 13 in Adults Age 18 Through 49
July 12, 2016 - Pfizer Inc. (NYSE:PFE) today announced that Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) received U.S. Food and Drug Administration (FDA) approval...
FDA Expands Use of Prevnar 13 Vaccine for People Ages 50 and Older
SILVER SPRING, Md., Dec. 30, 2011 /PRNewswire-USNewswire/ – Prevnar 13, a pneumococcal 13-valent conjugate vaccine, was approved today by the U.S. Food and Drug Administration for people ages 50...